New tablet shows promise for chronic hives in small study
NCT ID NCT07611032
First seen May 31, 2026 · Last updated Jun 05, 2026 · Updated 3 times
Summary
This study tested a daily tablet called NatureU Histra Disslove in 19 adults with chronic hives (urticaria). Participants took one tablet before a main meal for 28 days. The results showed better control of hives and improved quality of life, with no major safety concerns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dao County People's Hospital
Yongzhou, Hunan, 425300, China
Conditions
Explore the condition pages connected to this study.